The role of epithelial-mesenchymal transition in cancer pathology

Pathology

Volumn 39, Issue 3, 2007, Pages 305-318

  Guarino, Marcello ^a   Rubino, Barbara ^b   Ballabio, Gianmario ^c  

^a DESIO HOSPITAL   (Italy)

^b S Ambrogio Hospital   (Italy)

^c Borgomanero Hospital   (Italy)

Author keywords

Carcinoma progression; E cadherin; Epithelial mesenchymal transition; Molecular mechanisms; Tumour invasion

Indexed keywords

BETA CATENIN; GROWTH FACTOR; INTEGRIN; PROTEIN TYROSINE KINASE; RAS PROTEIN; UVOMORULIN; WNT PROTEIN;

BREAST CARCINOMA; CANCER CELL; CANCER GROWTH; CARCINOGENESIS; CELL INVASION; CELL MOTILITY; DOWN REGULATION; EPITHELIUM; GENE INACTIVATION; HISTOPATHOLOGY; HUMAN; MESENCHYME; PHENOTYPE; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; STOMACH CARCINOMA;

EID: 34250174504     PISSN: 00313025     EISSN: 14653931     Source Type: Journal    
DOI: 10.1080/00313020701329914     Document Type: Article

References (66)

1. Mareel M, Leroy A. Clinical, cellular, and molecular aspects of cancer invasion. Physiol Rev 2003; 83: 337-76.
2. Hirohashi S. Inactivation of the E-cadherin-mediated cell adhesion system in human cancer. Am J Pathol 1998; 153: 333-9.
3. Brabletz T, Hlubeck F, Spaderna S, et al. Invasion and metastasis in colorectal cancer: epithelial-mesenchymal transition, mesenchymal-epithelial transition, stem cells and b-catenin. Cells Tissues Organs 2005; 179: 56-65.
4. Hay ED. The mesenchymal cell, its role in the embryo, and the remarkable signaling mechanisms that create it. Dev Dyn 2005; 233: 706-20.
5. Guarino M. Epithelial-to-mesenchymal change of differentiation. From embryogenetic mechanism to pathological patterns. Histol Histopathol 1995; 10: 171-84.
6. Guarino M, Micheli P, Pallotti F, et al. Pathological relevance of epithelial and mesenchymal phenotype plasticity. Pathol Res Pract 1999; 195: 379-89.
7. Boyer B, Vallés AM, Edme N. Induction and regulation of epithelial-mesenchymal transitions. Biochem Pharmacol 2000; 60: 1091-9.
8. Nawshad A, LaGamba D, Polad A, et al. Transforming growth factor-β signaling during epithelial-mesenchymal transformation: implications for embryogenesis and tumor metastasis. Cells Tissues Organs 2005; 179: 11-23.
9. Xue C, Plieth D, Venkov C, et al. The gatekeeper effect of epithelial-mesenchymal transition regulates the frequency of breast cancer metastasis. Cancer Res 2003; 63: 3386-94.
10. Gilles C, Polette M, Zahm JM, et al. Vimentin contributes to human mammary epithelial migration. J Cell Sci 1999; 112: 4615-25.
11. Gilles C, Polette M, Mestdagt M, et al. Transactivation of vimentin by β-catenin in human breast cancer cells. Cancer Res 2003; 63: 2658-64.
12. Peinado H, Portillo F, Cano A. Transcriptional regulation of cadherins during development and carcinogenesis. Int J Dev Biol 2004; 48: 365-75.
13. Graff JR, Gabrielson E, Fujii H, et al. Methylation patterns of the E-cadherin 5′CpG island are unstable and reflect the dynamic, heterogeneous loss of E-cadherin expression during metastatic progression. J Biol Chem 2000; 275: 2727-32.
14. Barrallo-Gimeno A, Nieto MA. The Snail genes as inducers of cell movement and survival: implications in development and cancer. Development 2005; 132: 3151-61.
15. Cowin P, Rowlands TM, Hatsell SJ. Cadherins and catenins in breast cancer. Curr Opin Cell Biol 2005; 17: 1-10.
16. Shibata T, Kokubu A, Sekine S, et al. Cytoplasmatic p120ctn regulates the invasive phenotypes of E-cadherin-deficient breast cancer. Am J Pathol 2004; 164: 2269-78.
17. Yang J, Mani SA, Donaher JL, et al. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 2004; 117: 927-39.
18. Hulboy DL, Matrisian LM, Crawford HC. Loss of JunB activity enhances stromelysin 1 expression in a model of the epithelial-to-mesenchymal transition of mouse skin tumors. Mol Cell Biol 2001; 21: 5478-87.
19. Kustikova O, Kramerov D, Grigorian M, et al. Fra-1 induces morphological transformation and increases in vitro invasiveness and motility of epithelioid adenocarcinoma cells. Mol Cell Biol 1998; 18: 7095-105.
20. Davies M, Robinson M, Smith E, et al. Induction of an epithelial-mesenchymal transition in human immortal and malignant keratinocytes by TGF-β1 involves MAPK, Smad and AP-1 signalling pathways. J Cell Biochem 2005; 95: 918-31.
21. Hsu T, Trojanowska M, Watson DK. Ets proteins in biological control and cancer. J Cell Biochem 2004; 91: 896-903.
22. Kumar R. Another tie that binds the MTA family to breast cancer. Cell 2003; 113: 142-3.
23. Smith MEF, Pignatelli M. The molecular histology of neoplasia: the role of the cadherin/catenin complex. Histopathology 1997; 31: 107-111.
24. Lilien J, Balsamo J. The regulation of cadherin-mediated adhesion by tyrosine phosphorylation/dephosphorylation of β-catenin. Curr Opin Cell Biol 2005; 17: 1-7.
25. Avizienyte E, Frame MC. Src and FAK signalling controls adhesion fate and the epithelial-to-mesenchymal transition. Curr Opin Cell Biol 2005; 17: 542-7.
26. Malumbres M, Pellicer A. Ras pathways to cell cycle and cell transformation. Front Biosci 1998; 3: d887-912.
27. TakaiY, , Sasaki T, Matozaki T. Small GTP-binding proteins. Physiol Rev 2001; 81: 153-208.
28. Lamorte L, Royal I, Naujokas M, et al. Crk adapter proteins promote an epithelial-mesenchymal-like transition and are required for HGF-mediated cell spreading and breakdown of epithelial adherens junctions. Mol Biol Cell 2002; 13: 1449-61.
29. Montesano R, Soriano JV, Hosseini G, et al. Constitutively active mitogen-activated protein kinase kinase MEK1 disrupts morphogenesis and induces an invasive phenotype in Madin-Darby canine kidney cells. Cell Growth Differ 1999; 10: 317-32.
30. Grille SJ, Bellacosa A, Upson J, et al. The protein kinase Akt induces epithelial mesenchymal transition and promotes enhanced motility and invasiveness of squamous cell carcinoma lines. Cancer Res 2003; 63: 2172-8.
31. Zondag GCM, Evers EE, ten Klooster JP, et al. Oncogenic Ras downregulates Rac activity, which leads to increased Rho activity and epithelial-mesenchymal transition. J Cell Biol 2000; 149: 775-81.
32. Boyer B, Bourgeois Y, Poupon MF. Src kinase contributes to the metastatic spread of carcinoma cells. Oncogene 2002; 21: 2347-55.
33. Morali OG, Delmas V, Moore R, et al. IGF-II induces a rapid β-catenin relocation to the nucleus during epithelium to mesenchyme transition. Oncogene 2001; 20: 4942-50.
34. Conacci-Sorrell M, Simcha I, Ben-Yedidia T, et al. Autoregulation of E-cadherin expression by cadherin-cadherin interactions: the roles of β-catenin signalling, Slug, and MAPK. J Cell Biol 2003; 24: 847-857.
35. Boyer B, Roche S, Denoyelle M, et al. Src and Ras are involved in separate pathways in epithelial cell scattering. EMBO J 1997; 16: 5904-13.
36. Peinado H, Quintanilla M, Cano A. Transforming factor β-1 induces Snail transcription factor in epithelial cell lines. Mechanisms for epithelial mesenchymal transitions. J Biol Chem 2003; 278: 21113-23.
37. Xie L, Law BK, Chytil AM, et al. Activation of the Erk pathway is required for TGF-β1-induced EMT in vitro. Neoplasia 2004; 6: 603-10.
38. Bakin AV, Tomlinson AK, Bhowmick NA, et al. Phosphatidylinositol 3-kinase function is required for transforming factor β-mediated epithelial to mesenchymal transition and cell migration. J Biol Chem 2000; 275: 36803-10.
39. Zhou BP, Deng J, Xia W, et al. Dual regulation of Snail by GSK-3β-mediated phosphorylation in control of epithelial-mesenchymal transition. Nat Cell Biol 2004; 6: 931-40.
40. Keely PJ. Rho GTPases as early markers for tumour progression. Lancet 2001; 358: 1744-5.
41. Edme N, Downward J, Thiery JP, et al. Ras induces NBT-II cell scattering through the coordinate activities of Rac and MAPK pathways. J Cell Sci 2002; 115: 2591-601.
42. Benitah SA, Valeròn PF, Rui H, et al. STAT5a activation mediates the epithelial to mesenchymal transition induced by oncogenic RhoA. Mol Biol Cell 2003; 14: 40-53.
43. Bhowmick NA, Ghiassi M, Bakin A, et al. Transforming factor-β1mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism. Mol Biol Cell 2001; 12: 27-36.
44. Avizienyte E, Brunton VG, Fincham VJ, et al. The Scr-induced mesenchymal state in late-stage colon cancer cells. Cells Tissues Organs 2005; 179: 73-80.
45. Lee YI, Kwon YJ, Joo CK. Integrin-linked kinase function is required for transforming factor β-mediated epithelial to mesenchymal transition. Biochem Biophys Res Commun 2004; 316: 997-1001.
46. Novak A, Hsu SC, Leung-Hagesteijn C, et al. Cell adhesion and the integrin-linked kinase regulate the LEF-1 and β-catenin signaling pathways. Proc Natl Acad Sci 1998; 95: 4374-9.
47. Oft M, Peli J, Rudaz C, et al. TGF-β1 and Ha-Ras collaborate in modulating the phenotype plasticity and invasiveness of epithelial tumor cells. Genes Dev 1996; 10: 2462-77.
48. Bates RC, Mercurio AM. Tumor necrosis factor-α stimulates the epithelial-to-mesenchymal transition of human colonic organoids. Mol Biol Cell 2003; 14: 1790-800.
49. Nelson WJ, Nusse R. Convergence of Wnt, β-catenin, and cadherin pathways. Science 2004; 303: 1483-7.
50. Ding Q, Xia W, Liu JC, et al. Erk associates with and primes GSK-3β for its inactivation resulting in upregulation of β-catenin. Mol Cell 2005; 19: 159-70.
51. Bachelder RE, Yoon SO, Franci C, et al. Glycogen synthase kinase-3 is an endogenous inhibitor of Snail transcription: implications for the epithelial-mesenchymal transition. J Cell Biol 2005; 168: 29-33.
52. Lochter A, Galosy S, Muschler J, et al. Matrix metalloproteinase stromelysin-1 triggers a cascade of molecular alterations that lead to stable epithelial-to-mesenchymal transition and a premalignant phenotype in mammary epithelial cells. J Cell Biol 1997; 139: 1861-72.
53. Radisky DC, Levy DD, Littlepage LE, et al. Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability. Nature 2005; 436: 123-7.
54. Menke A, Philippi C, Vogelmann R, et al. Down-regulation of E-cadherin gene expression by collagen type I and type III in pancreatic cancer cell lines. Cancer Res 2001; 61: 3508-17.
55. Giancotti FG, Ruoslahti E. Integrin signaling. Science 1999; 285: 1028-32.
56. Vallés AM, Beuvin M, Boyer B. Activation of Rac1 by paxillin-Crk-DOCK180 signaling complex is antagonized by Rap1 in migrating NBT-II cells. J Biol Chem 2004; 279: 44490-6.
57. Wu C. Integrin-linked kinase and PINCH: partners in regulation of cell-extracellular matrix interaction and signal transduction. J Cell Sci 1999; 112: 4485-9.
58. Somasiri A, Howarth A, Goswami D, et al. Overexpression of the integrin-linked kinase mesenchymally transforms mammary epithelial cells. J Cell Sci 2000; 114: 1125-36.
59. Rosivatz E, Becker I, Specht K, et al. Differential expression of the epithelial-mesenchymal transition regulators Snail, SIP1, and Twist in gastric cancer. Am J Pathol 2002; 161: 1881-91.
60. Bellovin DI, Bates RC, Muzikansky A, et al. Altered localization of p120 catenin during epithelial to mesenchymal transition of colon carcinoma is prognostic for aggressive disease. Cancer Res 2005; 65: 10938-45.
61. Bates RC, Bellovin DI, Brown C, et al. Transcriptional activation of integrin β6 during the epithelial-mesenchymal transition defines a novel prognostic indicator of aggressive colon carcinoma. J Clin Invest 2005; 115: 339-47.
62. Berx G, Van Roy F. The E-cadherin/catenin complex: an important gatekeeper in breast cancer tumorigenesis and malignant progression. Breast Cancer Res 2001; 3: 289-93.
63. Bindels S, Mestdagt M, Vandewalle C, et al. Regulation of vimentin by SIP1 in human epithelial breast tumor cells. Oncogene 2006; 25: 4975-85.
64. De Craene B, Berx G. Snail in the frame of malignant tumor recurrence. Breast Cancer Res 2006; 8: 105.
65. Guarino M, Micheli P, Pallotti F, Giordano F. Pathological relevance of epithelial and mesenchymal phenotype plasticity. Pathol Res Pract 1999; 195: 379-89.
66. Guarino M. Epithelial-to-mesenchymal change of differentiation. From embryogenetic mechanism to pathological patterns. Histol Histopathol 1995; 10: 171-84.